CES 2021 Taiwanese biotech startup mProbe CADx develops AI health analysis platform
CES 2021 Taiwanese biotech startup mProbe CADx develops AI health analysis platform News provided by Share this article Share this article TAIPEI, Jan. 12, 2021 /PRNewswire/ -- mProbe Taiwan is a subsidiary biotechnology company of mProbe Inc, committed to promoting human health and wellness by transforming the field of precision health and precision medicine. With multi-omics as the critical evidence, mProbe has endeavored to interpret that evidence against a proprietary, vast clinically annotated, a library of phenotypes using artificial intelligence. The company uses a small amount of bl...
Source: prnewswire.com